Evidence map›Paper›PMID 41226270›Full record

ArticleMolecules (Basel, Switzerland)2025

In Vitro Anti-Inflammatory and Anticancer Potential of Pecan Nut (

Ifeoma Roseline Ezeanolue, Chiugo Francisca Ezeanolue, Pierluigi Plastina, Francieli Moro Stefanello, Rejane Giacomelli Tavares, Roselia Maria Spanevello

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ifeoma Roseline EzeanolueDepartment of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.ORCID 0009-0000-1996-0405
Chiugo Francisca EzeanolueFaculty of Pharmaceutical Sciences, University of Nigeria Nsukka, Nsukka, Enugu, Nigeria.
Pierluigi PlastinaDepartment of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.ORCID 0000-0002-8534-4130
Francieli Moro StefanelloCentre for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, University Campus S/N, Pelotas 96010-610, RS, Brazil.
Rejane Giacomelli TavaresCentre for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, University Campus S/N, Pelotas 96010-610, RS, Brazil.
Roselia Maria SpanevelloCentre for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, University Campus S/N, Pelotas 96010-610, RS, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This scoping review synthesized evidence from 2015 to 2025 on the anti-inflammatory and anticancer potential of pecan (

Indexed as

Anti-Inflammatory AgentsAntineoplastic Agents, PhytogenicCaryaNutsPlant ExtractsSignal TransductionAntioxidantsApoptosisCell Line, TumorHumansAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicAntioxidantsPlant Extractsanticanceranti-inflammatoryapoptosisbioactivesCarya illinoinensiscell signalingNF-κBscoping reviewurolithins

Identifiers

PMID41226270
PMCPMC12608562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.